Asthma — all decisions

The Board denied service connection for chronic sinusitis, fibromyalgia, and CFS. The Veteran's hearing loss, lumbar spine disability, radiculopathy, shoulder disability, knee meniscal tear, knee limitation of extension, knee scars, GERD, allergic rhinitis, asthma, and PTSD were also not rated higher than their current levels.

The Board denied service connection for hemorrhoids, irritable bowel syndrome (IBS), vertigo, rhinitis, sinusitis, and asthma as the evidence did not support a finding of a current disability or a link to active service. The claim for GERD was remanded for further development.

The Board granted a 30 percent initial rating for asthma, but remanded the claim for service connection of pseudofolliculitis barbae (PFB).

The Board granted service connection for asthma based on the Veteran's presumed exposure to fine particulate matter during his service in the Southwest Asia theater of operations during the Persian Gulf War.

The Board granted service connection for a heart condition as secondary to the Veteran's service-connected lymphedema and granted an initial 20% rating for a painful and unstable scar on the right mid-shin, effective April 14, 2022. Other claims were remanded.

The Board remands the claim for a more detailed examination to clarify the nature of the Veteran's respiratory disability and address possible complications, including whether the Veteran has COPD or emphysema.

The Board denied service connection for bilateral chondromalacia and dismissed the appeal for service connection for asthma due to untimely filing.

The Board denied the Veteran's claims for service connection for pneumonia and an increased rating for asthma, and remanded several other claims including those for heart condition, chronic low back condition, diabetes mellitus type II, GERD, hypertension, and sleep apnea.

The Board granted a 30 percent rating for asthma but denied all other claims, including service connection for various conditions and a compensable rating for scars between the scapulae.

The Board remands the claim for a toxic exposure risk activity (TERA) memorandum and an addendum medical opinion regarding whether the Veteran's asthma is related to his in-service herbicide exposure.

The Board granted a 60 percent rating for asthma from March 15, 2021 to October 21, 2024 and denied a higher rating after that date.

The Board denied the Veteran's claim for separate evaluations for obstructive sleep apnea and asthma, as they are not permitted by law.

The Veteran's asthma was granted a 100 percent rating prior to May 8, 2024, and the ratings for left and right lower extremity radiculopathy were increased from 10 percent to 20 percent.

The Board denied an increased rating for bipolar and related disorders, but remanded claims for service connection for hypertension, diabetes, diabetic peripheral neuropathy, and asthma.

The Board remands the claims for service connection for PTSD, asthma disorder, and Hodgkin's lymphoma to correct a pre-decisional error of the duty to assist.

The Board denied service connection for a pulmonary condition, to include COPD, asthma, and chronic bronchitis, finding that the evidence did not support a nexus between the Veteran's in-service toxic exposure and his current pulmonary condition.

The Board denied the veteran's appeals for service connection due to untimely filings.

The Board denied service connection for an acquired psychiatric disorder, including MDD and PTSD, as well as initial compensable ratings for right ear hearing loss and tinnitus. The claims for service connection for erectile dysfunction, a bilateral eye disorder, asthma, and a skin disorder were remanded.

The Board denied an increased disability rating in excess of 60 percent for bronchial asthma based on the evidence showing that the criteria for a higher rating were not met.

The Board remands the veteran's claims for further development, including obtaining additional evidence and completing necessary examinations.